X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21085) 21085
Book Chapter (292) 292
Dissertation (239) 239
Publication (35) 35
Conference Proceeding (23) 23
Book / eBook (11) 11
Government Document (9) 9
Magazine Article (7) 7
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
mtor (13403) 13403
humans (9716) 9716
animals (7272) 7272
rapamycin (4736) 4736
tor serine-threonine kinases - metabolism (4543) 4543
oncology (4506) 4506
cancer (4197) 4197
mice (4098) 4098
cell biology (3979) 3979
mammalian target (3915) 3915
phosphorylation (3847) 3847
signal transduction (3779) 3779
apoptosis (3737) 3737
female (3541) 3541
autophagy (3475) 3475
male (3448) 3448
biochemistry & molecular biology (3149) 3149
activation (3037) 3037
proteins (2911) 2911
expression (2820) 2820
akt (2774) 2774
cell line, tumor (2652) 2652
growth (2475) 2475
signal transduction - drug effects (2436) 2436
kinases (2331) 2331
tor protein (2197) 2197
proto-oncogene proteins c-akt - metabolism (2186) 2186
pathway (2052) 2052
tor serine-threonine kinases - antagonists & inhibitors (1961) 1961
inhibition (1888) 1888
sirolimus - pharmacology (1840) 1840
analysis (1716) 1716
pharmacology & pharmacy (1646) 1646
research (1589) 1589
tor serine-threonine kinases (1581) 1581
everolimus (1546) 1546
metabolism (1537) 1537
cell proliferation (1443) 1443
pi3k (1433) 1433
cell proliferation - drug effects (1399) 1399
gene expression (1396) 1396
phosphatidylinositol 3-kinases - metabolism (1372) 1372
middle aged (1363) 1363
cells (1318) 1318
tumors (1295) 1295
neurosciences (1269) 1269
tor serine-threonine kinases - genetics (1264) 1264
apoptosis - drug effects (1238) 1238
rats (1237) 1237
proliferation (1224) 1224
adult (1214) 1214
health aspects (1179) 1179
physiological aspects (1158) 1158
medicine, research & experimental (1135) 1135
care and treatment (1093) 1093
cell growth (1088) 1088
mechanistic target of rapamycin complex 1 (1060) 1060
cell cycle (1042) 1042
aged (1041) 1041
metastasis (1039) 1039
antineoplastic agents - pharmacology (1033) 1033
akt protein (1031) 1031
mtor inhibitors (1018) 1018
cells, cultured (997) 997
mutation (994) 994
biology (993) 993
chemotherapy (980) 980
survival (971) 971
kinase (956) 956
mtor pathway (937) 937
ampk (931) 931
therapy (927) 927
mtor inhibitor (906) 906
oxidative stress (905) 905
cell line (902) 902
signaling pathway (897) 897
mammalian target of rapamycin (894) 894
breast cancer (893) 893
protein (886) 886
immunology (884) 884
autophagy - drug effects (876) 876
signal transduction - physiology (874) 874
sirolimus - analogs & derivatives (870) 870
mice, inbred c57bl (866) 866
genetic aspects (864) 864
target (831) 831
in-vitro (827) 827
sirolimus - therapeutic use (824) 824
inflammation (822) 822
disease models, animal (821) 821
antineoplastic agents - therapeutic use (818) 818
protein kinases - metabolism (797) 797
sirolimus (776) 776
immunohistochemistry (770) 770
insulin (770) 770
protein kinase inhibitors - pharmacology (752) 752
differentiation (741) 741
signaling (736) 736
physiology (734) 734
pi3k/akt/mtor pathway (726) 726
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20672) 20672
Chinese (631) 631
French (200) 200
German (82) 82
Japanese (73) 73
Spanish (57) 57
Portuguese (53) 53
Korean (45) 45
Russian (30) 30
Polish (23) 23
Czech (12) 12
Hungarian (10) 10
Turkish (7) 7
Norwegian (5) 5
Dutch (3) 3
Swedish (3) 3
Italian (2) 2
Persian (2) 2
Slovak (2) 2
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biochemical journal, ISSN 0264-6021, 08/2007, Volume 405, Issue 3, pp. 513 - 522
The mTOR (mammalian target of rapamycin) protein kinase is an important regulator of cell growth. Two complexes of mTOR have been identified: complex 1,... 
Mammalian target of rapamycin (mTOR) | Protein kinase | Protein observed with Rictor-1 (Protor) | mTOR complex-2 (mTORC2) | Proline-rich repeat protein-5 (PRR-5) | Rapamycin-insensitive companion of mTOR (Rictor) | Cancer | PARTNER | proline-rich repeat protein-5 (PRR-5) | protein observed with Rictor-1 (Protor) | ACTIVATION | PHOSPHORYLATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | KINASE | mammalian target of rapamycin (mTOR) | rapamycin-insensitive companion of mTOR (Rictor) | protein kinase | RAPTOR | ORGANIZATION | REGULATOR | TOR | GROWTH | cancer | PDK1 | Protein Kinases - metabolism | Cell Line | Carrier Proteins - metabolism | Humans | Protein Isoforms | Gene Silencing | Protein Binding | TOR Serine-Threonine Kinases | Rapamycin-Insensitive Companion of mTOR Protein | HEK-293 cells, human embryonic kidney cells | SPAK, Ste20 | PI3K, phosphoinositide 3-kinase | mTORC, mTOR complex | EST, expressed sequence tag | Protor, protein observed with Rictor | DTT, dithiothreitol | HRP, horseradish peroxidase | PDK1, phosphoinositide-dependent kinase 1 | PKB, protein kinase B | NCBI, National Center for Biotechnology Information | IGF-1, insulin-like growth factor-1 | S6K, S6 kinase | mTOR, mammalian target of rapamycin | TAP, tandem affinity purification | Rictor, rapamycin-insensitive companion of mTOR | Raptor, regulatory associated protein of mTOR | siRNA, small interfering RNA | I.M.A.G.E., Integrated Molecular Analysis of Genomes and their Expression | SPS1-related proline | alanine-rich kinase
Journal Article
Nature communications, ISSN 2041-1723, 2018, Volume 9, Issue 1, pp. 4874 - 17
The metabolic checkpoint kinase mechanistic/mammalian target of rapamycin (mTOR) regulates natural killer (NK) cell development and function, but the exact... 
IMMUNITY | NATURAL-KILLER-CELLS | ACTIVATION | IFN-GAMMA PRODUCTION | METABOLISM | KINASE MTOR | MULTIDISCIPLINARY SCIENCES | DISEASE | IL-15 | LYMPHOID-CELLS | T-BET | Humans | Rapamycin-Insensitive Companion of mTOR Protein - deficiency | STAT5 Transcription Factor - immunology | T-Box Domain Proteins - immunology | Interleukin-15 - immunology | STAT5 Transcription Factor - genetics | Large Neutral Amino Acid-Transporter 1 - immunology | Rapamycin-Insensitive Companion of mTOR Protein - genetics | Rapamycin-Insensitive Companion of mTOR Protein - immunology | Killer Cells, Natural - immunology | Cell Differentiation | Interleukin-2 Receptor beta Subunit - genetics | Signal Transduction | Lymphocyte Activation | Regulatory-Associated Protein of mTOR - immunology | Mice, Inbred C57BL | Gene Expression Regulation | Large Neutral Amino Acid-Transporter 1 - genetics | Mice, Transgenic | T-Box Domain Proteins - genetics | Killer Cells, Natural - cytology | Animals | Interleukin-15 - genetics | Regulatory-Associated Protein of mTOR - deficiency | Mice | Interleukin-2 Receptor beta Subunit - immunology | Regulatory-Associated Protein of mTOR - genetics | TOR protein | Maturation | Stat5 protein | Rapamycin | Metabolism | Kinases | Interleukin 15 | Anticancer properties | Signaling | Cell activation | Clonal deletion | Kinetics | Natural killer cells | CD122 antigen
Journal Article
Pharmacological research, ISSN 1043-6618, 01/2015, Volume 91, pp. 57 - 68
Rapamycin, an inhibitor of mTOR activity, is a potent inducer of erythroid differentiation and fetal hemoglobin production in β-thalassemic patients.... 
mTOR | Sp1 | Erythroid induction | Raptor | Mithramycin | Fetal hemoglobin | KINASE | FETAL-HEMOGLOBIN | PHARMACOLOGY & PHARMACY | GLOBIN MESSENGER-RNA | DIFFERENTIATION | ACCUMULATION | J-J LOCUS | BETA-THALASSEMIA | PROMOTER SEQUENCES | PRECURSOR CELLS | DNA-BINDING DRUGS | TOR Serine-Threonine Kinases - metabolism | Humans | Multiprotein Complexes - genetics | Pyrrolidonecarboxylic Acid - analogs & derivatives | RNA, Messenger - metabolism | Pyrrolidonecarboxylic Acid - metabolism | Mechanistic Target of Rapamycin Complex 1 | Multiprotein Complexes - antagonists & inhibitors | TOR Serine-Threonine Kinases - antagonists & inhibitors | Multiprotein Complexes - metabolism | TOR Serine-Threonine Kinases - genetics | Adaptor Proteins, Signal Transducing - antagonists & inhibitors | Regulatory-Associated Protein of mTOR | Cell Differentiation | Rapamycin-Insensitive Companion of mTOR Protein | Promoter Regions, Genetic | Gene Expression | Oligopeptides - genetics | Oligopeptides - metabolism | Plicamycin - pharmacology | Carrier Proteins - genetics | Carrier Proteins - metabolism | Cell Cycle | Adaptor Proteins, Signal Transducing - genetics | K562 Cells | Adaptor Proteins, Signal Transducing - metabolism | Genetic aspects | Genetic transcription | TBS, tris-buffered saline | Rictor, rapamycin-insensitive companion of mTOR | FBS, fetal bovine serum | ODN, oligonucleotide | Raptor, regulatory associated protein of mTOR | Sp1, specific protein 1 | RAPA, rapamycin | ChIP, chromatin immunoprecipitation | HbF, fetal hemoglobin | mTORC1, mTOR complex 1 | MTH, mithramycin | PBS, phosphate-buffered saline | m-TORC2, mTOR complex 2 | mTOR, mammalian target of rapamycin | EMSA, electrophoretic mobility shift assay
Journal Article
Journal of virology, ISSN 1098-5514, 2019, Volume 93, Issue 12
Low-risk human papillomaviruses (LR-HPVs) are the causative agents of genital warts, which are a widespread sexually transmitted disease. How LR-HPVs affect... 
AKT/mTOR | Erk/mTOR | Autophagy | LR-HPV
Journal Article
Biochemical journal, ISSN 1470-8728, 2011, Volume 438, Issue 1, pp. 53 - 62
Genetic alterations in PI3K (phosphoinositide 3-kinase) signalling are common in cancer and include deletions in PTEN (phosphatase and tensin homologue deleted... 
Phosphoinositide 4-kinase (PI4K) | Pan-phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitor NVP-BEZ235; phosphoinositide 3-kinase α (PI3Kα) | PIK3CA | p110α E545k mutation | PIK3CA H1047R mutation | PIK3CA MUTATIONS | BIOCHEMISTRY & MOLECULAR BIOLOGY | p110 alpha E545K mutation | PTEN | phosphoinositide 4-kinase (PI4K) | PI3K-ALPHA | PROLIFERATION | CANCER | pan-phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitor NVP-BEZ235 | INSULIN | P110-BETA | phosphoinositide 3-kinase alpha (PI3K alpha) | ROLES | INHIBITORS | IA PI3K ISOFORMS | Class Ia Phosphatidylinositol 3-Kinase - metabolism | Humans | Neoplasms, Experimental - prevention & control | Enzyme Inhibitors - therapeutic use | Class Ia Phosphatidylinositol 3-Kinase - antagonists & inhibitors | Mice, Knockout | Neoplasms, Experimental - pathology | Tissue Distribution | Animals | Enzyme Inhibitors - pharmacokinetics | Signal Transduction - drug effects | Protein Isoforms | Mice | Neoplasms, Experimental - metabolism | Tumor Cells, Cultured | Homeodomain Proteins - physiology | Proto-Oncogene Proteins c-akt - metabolism | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | PI3K, phosphoinositide 3-kinase | BID, twice daily dosing | p110α E545K mutation | mammalian target of rapamycin (mTOR) inhibitor NVP-BEZ235; phosphoinositide 3-kinase α (PI3Kα) | PTEN, phosphatase and tensin homologue deleted on chromosome 10 | ERK, extracellular-signal-regulated kinase | PKB, protein kinase B | pan-phosphoinositide 3kinase (PI3K) | PI4K, phosphoinositide 4-kinase | QD, once daily dosing | mTOR, mammalian target of rapamycin | TGI, tumour growth inhibition
Journal Article
Geburtshilfe und Frauenheilkunde, ISSN 0016-5751, 10/2017, Volume 77, Issue 10, pp. 1095 - 1103
Abstract The high recurrence rate and the low overall survival in ovarian cancer suggest that a more specific therapeutic approach in addition to conventional... 
GebFra Science | mTOR inhibitors | everolimus | PI3K/AKT/mTOR | temsirolimus | ovarian cancer | target therapy | PHOSPHATIDYLINOSITOL KINASE | ADVANCED SOLID TUMORS | GYNECOLOGIC-ONCOLOGY-GROUP | PHASE-II | OPEN-LABEL | OBSTETRICS & GYNECOLOGY | CIRCULATING TUMOR-CELLS | THERAPEUTIC TARGET | RECURRENT EPITHELIAL OVARIAN | MTOR INHIBITOR
Journal Article
by Xia, P and Xu, XY
AMERICAN JOURNAL OF CANCER RESEARCH, ISSN 2156-6976, 2015, Volume 5, Issue 5, pp. 1602 - 1609
Cancer stem cells (CSCs) are a subpopulation of tumor cells that possess unique self-renewal activity and mediate tumor initiation and propagation. The... 
ROTTLERIN INDUCES AUTOPHAGY | SIDE POPULATION | ACTIVATION | PANCREATIC-CANCER | MTOR PATHWAY | ACUTE MYELOID-LEUKEMIA | OVARIAN-CANCER | tumor initiation | PI3K/MTOR PATHWAY | PI3K/Akt/mTOR signaling pathway | EPITHELIAL-MESENCHYMAL TRANSITION | BREAST-CANCER | self-renew | ONCOLOGY | Cancer stem cells | rapamycin
Journal Article
Cancer cell, ISSN 1535-6108, 03/2017, Volume 31, Issue 3, pp. 424 - 435
Journal Article
Clinical science (1979), ISSN 0143-5221, 04/2012, Volume 122, Issue 7, pp. 349 - 359
DEPTOR [DEP-domain-containing and mTOR (mammalian target of rapamycin)-interacting protein] is a modulator of mTOR signalling that binds to mTORC (mTOR... 
Cortisol | DEP-domain-containing and mammalian target of rapamycin-interacting protein (DEPTOR) | Mammalian | RAPAMYCIN | MEDICINE, RESEARCH & EXPERIMENTAL | mammalian target of rapamycin (mTOR) | MTOR | cortisol | maternal stress | TOR | GROWTH | placenta | BIRTH | OUTCOMES | CORTISOL-LEVELS | Cell Line | Demography | TOR Serine-Threonine Kinases - metabolism | Humans | Intracellular Signaling Peptides and Proteins | Pregnancy - psychology | Protein Transport - drug effects | Down-Regulation - drug effects | Placenta - drug effects | Placenta - metabolism | Carrier Proteins - genetics | Stress, Psychological - genetics | Carrier Proteins - metabolism | TOR Serine-Threonine Kinases - genetics | Pregnancy - metabolism | Stress, Psychological - metabolism | Adaptor Proteins, Signal Transducing - genetics | Fluorescent Antibody Technique | Polymerase Chain Reaction | Female | Regulatory-Associated Protein of mTOR | Hydrocortisone - pharmacology | Adaptor Proteins, Signal Transducing - metabolism | Rapamycin-Insensitive Companion of mTOR Protein | Index Medicus | DEPTOR, DEP-domain-containing and mammalian target of rapamycin-interacting protein; FBS, fetal bovine serum | rictor, rapamycin-insensitive companion of mTOR | CS, Caesarean section | RQ, relative quantity S6K1, S6 kinase 1 | DAPI, 4′,6-diamidino-2-phenylindole | mTORC, mTOR complex | BMI, body mass index | raptor, regulatory associated protein of mTOR | IUGR, intrauterine growth restriction | GβL, G-protein β-like | mTOR, mammalian target of rapamycin | Q-PCR, quantitative PCR | MEM, minimal essential medium
Journal Article
Journal of Animal Science, ISSN 0021-8812, 12/2018, Volume 96, Issue suppl_3, pp. 495 - 496
Abstract Suboptimal nutrient intake represents a limiting factor for growth and long-term survival of low-birth weight infants. Both nutrient intolerance and... 
leucine | mTOR | neonate | Abstracts
Journal Article
Journal of genetics and genomics, ISSN 1673-8527, 2019, Volume 46, Issue 2, pp. 65 - 74
Journal Article
Journal Article